In lung cancer, breast cancer, and pancreatic cancer, expression of Nectin-4 or detection of Nectin-4 in serum was associated with tumors progression or poor survival [22–24, 26]. This evidence concerns the gene NECTIN4 and pancreatic neoplasm.